nodes	percent_of_prediction	percent_of_DWPC	metapath
Treprostinil—PPARD—Adipogenesis—ZMPSTE24—focal segmental glomerulosclerosis	0.077	0.116	CbGpPWpGaD
Treprostinil—P2RY12—Signal amplification—GNAQ—focal segmental glomerulosclerosis	0.0369	0.0553	CbGpPWpGaD
Treprostinil—PPARD—Ectoderm Differentiation—PODXL—focal segmental glomerulosclerosis	0.0358	0.0538	CbGpPWpGaD
Treprostinil—PTGIR—Prostaglandin Synthesis and Regulation—EDN1—focal segmental glomerulosclerosis	0.027	0.0405	CbGpPWpGaD
Treprostinil—PTGIR—Endothelin Pathways—EDN1—focal segmental glomerulosclerosis	0.025	0.0376	CbGpPWpGaD
Treprostinil—PTGIR—Thromboxane A2 receptor signaling—GNAQ—focal segmental glomerulosclerosis	0.0211	0.0317	CbGpPWpGaD
Treprostinil—PTGIR—Platelet homeostasis—TRPC6—focal segmental glomerulosclerosis	0.0194	0.0291	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—ACTN4—focal segmental glomerulosclerosis	0.0191	0.0287	CbGpPWpGaD
Treprostinil—Viral infection—Cyclosporine—focal segmental glomerulosclerosis	0.0142	0.0424	CcSEcCtD
Treprostinil—Rectal haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.0142	0.0424	CcSEcCtD
Treprostinil—Cellulitis—Cyclosporine—focal segmental glomerulosclerosis	0.0141	0.0421	CcSEcCtD
Treprostinil—Gout—Cyclosporine—focal segmental glomerulosclerosis	0.0137	0.041	CcSEcCtD
Treprostinil—PPARD—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—focal segmental glomerulosclerosis	0.0134	0.0201	CbGpPWpGaD
Treprostinil—Cramps of lower extremities—Cyclosporine—focal segmental glomerulosclerosis	0.0117	0.0352	CcSEcCtD
Treprostinil—Sepsis—Cyclosporine—focal segmental glomerulosclerosis	0.0111	0.0332	CcSEcCtD
Treprostinil—PPARD—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—focal segmental glomerulosclerosis	0.0099	0.0149	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—ACTN4—focal segmental glomerulosclerosis	0.00984	0.0148	CbGpPWpGaD
Treprostinil—PTGIR—Platelet homeostasis—NOS2—focal segmental glomerulosclerosis	0.00953	0.0143	CbGpPWpGaD
Treprostinil—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.00951	0.0285	CcSEcCtD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—TRPC6—focal segmental glomerulosclerosis	0.00916	0.0138	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—ACTN4—focal segmental glomerulosclerosis	0.00906	0.0136	CbGpPWpGaD
Treprostinil—PPARD—Adipogenesis—LPL—focal segmental glomerulosclerosis	0.0089	0.0134	CbGpPWpGaD
Treprostinil—P2RY12—G alpha (i) signalling events—AGTR2—focal segmental glomerulosclerosis	0.00867	0.013	CbGpPWpGaD
Treprostinil—P2RY12—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	0.00805	0.0121	CbGpPWpGaD
Treprostinil—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.00772	0.0231	CcSEcCtD
Treprostinil—Abdominal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00769	0.023	CcSEcCtD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—GNAQ—focal segmental glomerulosclerosis	0.00766	0.0115	CbGpPWpGaD
Treprostinil—PPARD—Adipogenesis—AGT—focal segmental glomerulosclerosis	0.00761	0.0114	CbGpPWpGaD
Treprostinil—PTGIR—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	0.0074	0.0111	CbGpPWpGaD
Treprostinil—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.0072	0.0215	CcSEcCtD
Treprostinil—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.00713	0.0213	CcSEcCtD
Treprostinil—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00695	0.0208	CcSEcCtD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.00689	0.0104	CbGpPWpGaD
Treprostinil—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.00682	0.0204	CcSEcCtD
Treprostinil—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.00675	0.0202	CcSEcCtD
Treprostinil—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.00671	0.0201	CcSEcCtD
Treprostinil—P2RY12—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	0.00659	0.00989	CbGpPWpGaD
Treprostinil—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.00645	0.0193	CcSEcCtD
Treprostinil—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.00644	0.0193	CcSEcCtD
Treprostinil—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00642	0.0192	CcSEcCtD
Treprostinil—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.00637	0.0191	CcSEcCtD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.00634	0.00953	CbGpPWpGaD
Treprostinil—P2RY12—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.00619	0.00929	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	0.00606	0.00911	CbGpPWpGaD
Treprostinil—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.00596	0.0178	CcSEcCtD
Treprostinil—PPARD—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—focal segmental glomerulosclerosis	0.00587	0.00881	CbGpPWpGaD
Treprostinil—PPARD—Adipogenesis—SERPINE1—focal segmental glomerulosclerosis	0.00585	0.00879	CbGpPWpGaD
Treprostinil—PTGIR—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.00569	0.00855	CbGpPWpGaD
Treprostinil—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.00549	0.0164	CcSEcCtD
Treprostinil—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00543	0.0162	CcSEcCtD
Treprostinil—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.00537	0.0161	CcSEcCtD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.0053	0.00796	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.00525	0.00788	CbGpPWpGaD
Treprostinil—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00519	0.0155	CcSEcCtD
Treprostinil—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00517	0.0155	CcSEcCtD
Treprostinil—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.00511	0.0153	CcSEcCtD
Treprostinil—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00504	0.0151	CcSEcCtD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.00488	0.00733	CbGpPWpGaD
Treprostinil—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.00488	0.0146	CcSEcCtD
Treprostinil—PTGIR—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.00483	0.00726	CbGpPWpGaD
Treprostinil—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00476	0.0142	CcSEcCtD
Treprostinil—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00476	0.0142	CcSEcCtD
Treprostinil—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.00476	0.0142	CcSEcCtD
Treprostinil—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00474	0.0142	CcSEcCtD
Treprostinil—P2RY12—Hemostasis—TRPC6—focal segmental glomerulosclerosis	0.00472	0.00709	CbGpPWpGaD
Treprostinil—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.0047	0.0141	CcSEcCtD
Treprostinil—P2RY12—G alpha (i) signalling events—AGT—focal segmental glomerulosclerosis	0.00469	0.00705	CbGpPWpGaD
Treprostinil—PPARD—Generic Transcription Pathway—CTGF—focal segmental glomerulosclerosis	0.00469	0.00704	CbGpPWpGaD
Treprostinil—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00456	0.0137	CcSEcCtD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—FN1—focal segmental glomerulosclerosis	0.00455	0.00684	CbGpPWpGaD
Treprostinil—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.00453	0.0136	CcSEcCtD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.00449	0.00675	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.00448	0.00672	CbGpPWpGaD
Treprostinil—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00447	0.0134	CcSEcCtD
Treprostinil—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.00435	0.013	CcSEcCtD
Treprostinil—PTGIR—Hemostasis—TRPC6—focal segmental glomerulosclerosis	0.00435	0.00653	CbGpPWpGaD
Treprostinil—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00416	0.0124	CcSEcCtD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.00414	0.00621	CbGpPWpGaD
Treprostinil—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00413	0.0123	CcSEcCtD
Treprostinil—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.0041	0.0123	CcSEcCtD
Treprostinil—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00407	0.0122	CcSEcCtD
Treprostinil—P2RY12—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.00404	0.00606	CbGpPWpGaD
Treprostinil—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00402	0.012	CcSEcCtD
Treprostinil—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00397	0.0119	CcSEcCtD
Treprostinil—P2RY12—Hemostasis—GNAQ—focal segmental glomerulosclerosis	0.00395	0.00593	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.00394	0.00592	CbGpPWpGaD
Treprostinil—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00393	0.0118	CcSEcCtD
Treprostinil—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.0039	0.0117	CcSEcCtD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—SERPINE1—focal segmental glomerulosclerosis	0.00379	0.00569	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—ALB—focal segmental glomerulosclerosis	0.00378	0.00568	CbGpPWpGaD
Treprostinil—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00376	0.0113	CcSEcCtD
Treprostinil—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00373	0.0112	CcSEcCtD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00373	0.0056	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.00372	0.00558	CbGpPWpGaD
Treprostinil—PPARD—Adipogenesis—TGFB1—focal segmental glomerulosclerosis	0.0037	0.00555	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—GNAQ—focal segmental glomerulosclerosis	0.00363	0.00546	CbGpPWpGaD
Treprostinil—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00361	0.0108	CcSEcCtD
Treprostinil—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00361	0.0108	CcSEcCtD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00343	0.00516	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00342	0.00514	CbGpPWpGaD
Treprostinil—PPARD—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	0.00337	0.00506	CbGpPWpGaD
Treprostinil—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00327	0.0098	CcSEcCtD
Treprostinil—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00323	0.00966	CcSEcCtD
Treprostinil—PTGIR—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00315	0.00473	CbGpPWpGaD
Treprostinil—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00312	0.00934	CcSEcCtD
Treprostinil—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00302	0.00903	CcSEcCtD
Treprostinil—P2RY12—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00298	0.00448	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00297	0.00446	CbGpPWpGaD
Treprostinil—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.0029	0.00868	CcSEcCtD
Treprostinil—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00288	0.00861	CcSEcCtD
Treprostinil—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00287	0.0086	CcSEcCtD
Treprostinil—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00286	0.00855	CcSEcCtD
Treprostinil—P2RY12—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00284	0.00427	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.0028	0.00421	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00275	0.00412	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.00273	0.0041	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00273	0.0041	CbGpPWpGaD
Treprostinil—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00271	0.00811	CcSEcCtD
Treprostinil—P2RY12—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00271	0.00407	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00269	0.00405	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00261	0.00393	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00258	0.00387	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00258	0.00387	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00249	0.00375	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00249	0.00375	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00248	0.00372	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	0.00239	0.00359	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00237	0.00356	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—FN1—focal segmental glomerulosclerosis	0.00235	0.00353	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.00234	0.00351	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—NOS2—focal segmental glomerulosclerosis	0.00232	0.00348	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.0023	0.00345	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00228	0.00343	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00227	0.0034	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—CTGF—focal segmental glomerulosclerosis	0.00226	0.00339	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00218	0.00327	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—FN1—focal segmental glomerulosclerosis	0.00216	0.00324	CbGpPWpGaD
Treprostinil—PPARD—Generic Transcription Pathway—SERPINE1—focal segmental glomerulosclerosis	0.00214	0.00321	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—NOS2—focal segmental glomerulosclerosis	0.00213	0.00321	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.0021	0.00315	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00208	0.00313	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00207	0.00311	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.002	0.00301	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—LIPC—focal segmental glomerulosclerosis	0.00199	0.00299	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	0.00195	0.00293	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—ALB—focal segmental glomerulosclerosis	0.00195	0.00293	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00193	0.0029	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00191	0.00286	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	0.0018	0.0027	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—ALB—focal segmental glomerulosclerosis	0.00179	0.00269	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.00179	0.00269	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00178	0.00267	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00176	0.00264	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—CTGF—focal segmental glomerulosclerosis	0.00175	0.00264	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.00162	0.00243	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00162	0.00243	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.00161	0.00241	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.0016	0.0024	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00159	0.00239	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.00148	0.00222	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.00147	0.00221	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00146	0.0022	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.00146	0.00219	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.00134	0.00201	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.00134	0.00201	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—TGFB1—focal segmental glomerulosclerosis	0.00123	0.00185	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.00123	0.00185	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.00122	0.00184	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—LPL—focal segmental glomerulosclerosis	0.00122	0.00183	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—TGFB1—focal segmental glomerulosclerosis	0.00113	0.0017	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.00113	0.00169	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—AGT—focal segmental glomerulosclerosis	0.00104	0.00156	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.00104	0.00156	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—SERPINE1—focal segmental glomerulosclerosis	0.00103	0.00155	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.00101	0.00151	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000955	0.00143	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000953	0.00143	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000926	0.00139	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.0009	0.00135	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000877	0.00132	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000861	0.00129	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—ALB—focal segmental glomerulosclerosis	0.000799	0.0012	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000796	0.0012	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000793	0.00119	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000792	0.00119	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000732	0.0011	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000662	0.000994	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000609	0.000915	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000549	0.000825	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000507	0.000762	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.00047	0.000706	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000467	0.000701	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000418	0.000628	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000401	0.000602	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000385	0.000578	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.000361	0.000542	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000353	0.00053	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000325	0.000488	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—LPL—focal segmental glomerulosclerosis	0.000245	0.000367	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—AGT—focal segmental glomerulosclerosis	0.000209	0.000314	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ALB—focal segmental glomerulosclerosis	0.000161	0.000241	CbGpPWpGaD
